{
  "resourceType": "Evidence",
  "id": "example-stroke-alteplase-fatalICH",
  "text": {
    "status": "generated",
    "div": "\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\n      \n      \u003cp\u003e\n        \u0026quot;Risk of fatal ICH with alteplase for stroke\u0026quot; is a univariate risk estimate.\n      \u003c/p\u003e\n\t\n    \u003c/div\u003e"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode": "cds"
    }
  ],
  "url": "http://hl7.org/fhir/Evidence/example-stroke-alteplase-fatalICH",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.4.642.10.1"
    }
  ],
  "name": "RiskOfFatalICHWithAlteplaseForStroke",
  "title": "Risk of fatal ICH with alteplase for stroke",
  "status": "draft",
  "publisher": "HL7 International / Clinical Decision Support",
  "contact": [
    {
      "telecom": [
        {
          "system": "url",
          "value": "http://www.hl7.org/Special/committees/dss"
        }
      ]
    }
  ],
  "relatesTo": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/artifact-relationship-type",
            "code": "cites",
            "display": "Cites"
          }
        ]
      },
      "targetMarkdown": "Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. \u003cb\u003eCitation:\u003c/b\u003e Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al;Stroke Thrombolysis Trialists\u0027 Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014 Nov 29;384(9958):1929-35 PMID 25106063 \u003cb\u003eURL:\u003c/b\u003e https://doi.org/10.1016/S0140-6736(14)60584-5"
    }
  ],
  "description": "2.7% incidence of fatal intracranial hemorrhage within 7 days with alteplase in patients with acute ischemic stroke",
  "variableDefinition": [
    {
      "variableRole": "population",
      "observed": {
        "reference": "Group/Emberson-2014-IPD-MA-Alteplase-Cohort",
        "type": "Group",
        "display": "Emberson 2014 IPD-MA Alteplase Cohort"
      },
      "intended": {
        "reference": "Group/AcuteIschemicStrokeTreatedWithAlteplase",
        "type": "Group",
        "display": "adults with acute ischemic stroke treated with alteplase"
      }
    },
    {
      "variableRole": "outcome",
      "observed": {
        "reference": "EvidenceVariable/example-fatal-ICH-in-7-days",
        "type": "EvidenceVariable",
        "display": "fatal ICH"
      },
      "intended": {
        "reference": "EvidenceVariable/example-fatal-ICH-in-7-days",
        "type": "EvidenceVariable",
        "display": "fatal ICH"
      }
    }
  ],
  "synthesisType": [
    {
      "coding": [
        {
          "system": "http://terminology.hl7.org/CodeSystem/synthesis-type",
          "code": "IPD-MA",
          "display": "individual patient data meta-analysis"
        }
      ]
    }
  ],
  "studyDesign": [
    {
      "coding": [
        {
          "system": "https://fevir.net/sevco",
          "code": "SEVCO:01003",
          "display": "randomized assignment"
        }
      ]
    }
  ],
  "statistic": [
    {
      "statisticType": {
        "coding": [
          {
            "system": "https://fevir.net/sevco",
            "code": "STATO:0000607",
            "display": "proportion"
          }
        ]
      },
      "quantity": {
        "value": 0.026835741669
      },
      "numberOfEvents": 91,
      "sampleSize": {
        "numberOfStudies": 9,
        "numberOfParticipants": 3391
      }
    }
  ]
}